| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 Jul 2026 | 22 Jul 2026 |
| Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the First Quarter ended on 30th June, 2026. UNAUDITED FINANCIAL RESULTS - 30.06.2026. Outcome of Board Meeting held on Monday, 27th July, 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the First Quarter ended 30th June, 2026. (As Per BSE Announcement Dated on:27.07.2026) | ||
| Board Meeting | 2 May 2026 | 27 Apr 2026 |
| Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2026 inter alia to consider and approve Audited Financial Results for the Fourth Quarter and Year ended 31.03.2026 and recommendation of Final Dividend if any. Approved Audited Financial Results (Standalone & Consolidated) for the Fourth Quarter and Year ended on 31st March, 2026 and Recommended Final dividend of Rs. 5.00 (50%) per Equity Share of face value of Rs. 10/- each for the Financial Year 2025-26. APPROVAL OF AUDITED FINANCIAL RESULTS AS ON 31.03.2026. (As Per BSE Announcement dated On : 02.05.2026) | ||
| Board Meeting | 30 Jan 2026 | 20 Jan 2026 |
| Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the Third Quarter and Nine Months ended on 31st December 2025. UNAUDITED FINANCIAL RESULTS AS ON 31.12.2025. (As Per BSE Announcement Dated on: 30/01/2026) | ||
| Board Meeting | 10 Nov 2025 | 4 Nov 2025 |
| Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the Second Quarter and Half Year ended on 30th September 2025. 1. Approved Un-Audited (Standalone & Consolidated) Financial Results of the Company for the Second Quarter and Half Year ended on 30th September, 2025; and took on record Limited Review Report thereon issued by M/s. S R B C & CO LLP, Statutory Auditors of the Company. 2. Appointment of Mr. Rakesh Agrawal as a Chief Financial Officer and Key Managerial Personnel of the Company with effect from 10th November, 2025 (As per BSE Announcement dated on: 10.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
